Skip to main content
PBF logo

PBF — Investor Relations & Filings

Ticker · 1760 ISIN · TW0001760007 LEI · 54930078VUU2LBPR2729 TW Manufacturing
Open in API
Filings indexed 1,562 across all filing types
Latest filing 2021-05-14 Regulatory Filings
Country TW Taiwan
Listing TW 1760

About PBF

http://www.pbf.com.tw

Panion & BF Biotech Inc. is a biotechnology company focused on pharmaceutical research, development, and manufacturing. Founded in 1976, the firm operates across several core sectors, including new drug innovation, medical aesthetics, and nutritional supplements. It is recognized for its "Total Aging Management" strategy, which addresses the health needs of an aging population through a diverse product portfolio. Key offerings include treatments for chronic kidney disease, specifically phosphate binders, as well as dermatological drugs, hair care solutions, and rapid diagnostic technologies. The company integrates clinical-grade pharmaceutical standards into its consumer health and aesthetic products, serving markets in chronic disease care and preventative wellness.

Recent filings

Filing Released Lang Actions
110年第1季大陸投資
Regulatory Filings Classification · 95% confidence The document is a detailed tabular disclosure of investment amounts and related financial figures concerning the company's investments in mainland China. It includes specific financial data such as capital amounts, investment methods, cumulative investment amounts, and investment income recognized for the period. The document is relatively short (1926 characters) and appears to be a regulatory disclosure of investment information rather than a full financial report or earnings release. It does not contain comprehensive financial statements or management discussion but is a regulatory compliance disclosure related to investment activities. This type of document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2021-05-14 Chinese
公告本公司提報董事會110年度第一季合併財務報告
Regulatory Filings Classification · 95% confidence The document is a short announcement (907 characters) reporting the submission of the company's first quarter consolidated financial report to the board of directors. It includes summarized financial data for the period 110/01/01 to 110/03/31 (Taiwan calendar year), such as revenue, gross profit, net loss, total assets, liabilities, and equity. The document states the report was submitted to the board on 110/05/13 but does not contain the full financial statements or detailed analysis itself. Given the short length and nature of the content, this is an announcement of the filing of an interim/quarterly report rather than the report itself. According to the "Menu vs Meal" rule, such announcements are classified as Regulatory Filings (RNS) rather than the full Interim Report (IR).
2021-05-13 Chinese
110年4月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, providing information about loan balances and guarantee endorsements for the current and previous months. It contains tabular data on financial limits and balances but does not include comprehensive financial statements or detailed analysis. The document length is very short (613 characters), and it appears to be a regulatory disclosure of specific financial data rather than a full report. It does not fit the criteria for Annual Report, Interim Report, or Earnings Release. It is not a certification or announcement of a report but a direct disclosure of financial information. Given the nature and brevity, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2021-05-10 Chinese
110年4月營業收入
Regulatory Filings Classification · 95% confidence The document is a summarized revenue report for a listed company, showing monthly and cumulative net operating revenue figures with percentage changes compared to the previous year. It includes notes on accounting standards (IFRS) and reporting practices. The document length is short (765 characters) and it does not contain detailed financial statements or comprehensive analysis. It appears to be a regulatory disclosure of revenue figures rather than a full financial report or earnings release. Given the nature and length, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-05-10 Chinese
110年04月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, managers, and their related parties. It shows the number of shares held, changes in holdings, and classifications of shares. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There is no indication of a full financial report, earnings release, or meeting materials. The document is a report of personal share transactions and holdings by company directors and executives, which fits the definition of Director's Dealing (DIRS). The document length is sufficient and contains substantive data on insider holdings, not just an announcement or certification.
2021-05-05 Chinese
110年04月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings and pledged shares by insiders and related parties of the company 寶齡富錦生技股份有限公司. It lists positions such as Chairman, Directors, General Manager, and other executives along with their shareholdings and pledged shares. The document length is about 3000 characters, which is relatively short and focused solely on insider shareholdings. There is no indication of financial results, earnings, management discussion, or other report content. The content matches the description of a Director's Dealing report, which reports personal share transactions or holdings by company directors and executives. Therefore, the appropriate classification is Director's Dealing (DIRS).
2021-05-05 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.